ME/CFS research: where the science is heading
For decades, ME/CFS was heavily stigmatised and largely ignored by major medical institutions. Because standard blood tests often came back normal, many doctors dismissed it as psychological, and research funding was almost nonexistent.
That is starting to change. Progress is still slower than people with ME/CFS need it to be. But researchers at major universities are now dedicating their careers to understanding this illness, and serious funding is beginning to move into the field.
The Long Covid turning point
The COVID-19 pandemic brought a large number of new Long Covid patients into the medical system. Because a significant proportion of people with Long Covid meet the criteria for ME/CFS, the medical world has had to engage with post-viral illness in a way it had not previously.
That shift in attention is benefiting ME/CFS research. Investigators are now studying the mechanics of post-viral illness at a scale that was not possible before.
Funding
On 13 November 2025, the German government committed €500 million to a ten-year National Decade Against Post-Infectious Diseases, covering ME/CFS and Long Covid research from 2026 to 2036. It is the largest public commitment to ME/CFS research to date.
In the UK, the DecodeME study — jointly funded by the MRC and NIHR — is analysing samples from 20,000 people with ME/CFS to identify genetic differences that may underlie the illness.The Netherlands, Australia, and Canada have also committed dedicated public funding.
The picture is not uniformly positive. The US remains significantly underfunded relative to the scale of the illness. France, Italy, Spain, and most of Asia have little or no dedicated public funding. But the direction of travel, for the first time in 40 years, is in the right direction.
What scientists are studying
Researchers are investigating several theories about what goes wrong in ME/CFS.
Energy and the Brain
- Mitochondrial dysfunction. Research is examining why cells fail to produce energy normally and why exertion triggers the kind of collapse seen in PEM.
- Neuroinflammation. Advanced brain imaging has found evidence of neuroinflammation in some people with ME/CFS. These findings support the hypothesis of a physical neurological basis for the illness, though research in this area is ongoing and not yet definitive.
Immunity and the Gut
- Autoimmunity and viral persistence. Researchers are investigating whether ME/CFS involves an autoimmune process, or whether viral material remains in the body’s tissues after the initial infection has cleared.
- The gut microbiome. Studies consistently find differences in the gut bacteria of people with ME/CFS, particularly in bacteria associated with inflammation and energy regulation.
These are active research areas, not settled conclusions. Findings are promising but preliminary.
Is a treatment coming?
Researchers are running clinical trials on existing medications to determine whether any can reliably ease specific symptoms. The realistic near-term goal is not a cure — it is finding treatments that raise the baseline and return some quality of life to people with ME/CFS.
There are now more researchers working on this illness, more funding behind them, and more international coordination than at any previous point. For people living with ME/CFS today, that does not change the immediate picture. But it does mean the field is no longer standing still.